Wound Debridement Market to grow by USD 474.77 million from 2022 to 2027, North America to account for 38% of market growth- Technavio

NEW YORK, Sept. 11, 2023 /PRNewswire/ -- The wound debridement market is expected to grow by USD 474.77 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 7.31% during the forecast period, according to Technavio Research. The market is segmented by end-user (hospitals, clinics, and others), product (autolytic, surgical, mechanical, enzymatic, and others), and geography (North America, Europe, Asia, and Rest of the World (ROW)). North America is estimated to contribute 38% to the growth of the global market during the forecast period. The largest market share of wound debridement is held by North America. The main contributing countries of the region are the US and Canada. The US is the largest market in the region. The growth of this market in North America is due to the increasing incidence of acute and chronic wounds, an increase in surgical procedures, increasing adoption of technologically advanced NPWT devices, increasing awareness of awareness among patients and healthcare workers, development of advanced health infrastructure, higher spending on health services; and wide market presence of major players. However, the lack of qualified wound excision specialists, and the decreasing number of burn-related deaths and injuries in the US, have resulted in fewer burn centers in the US and intense competition among suppliers. Hence, these factors are expected to drive market growth in the region during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Sample Report

Company Profile:

Arobella Medical LLC, B.Braun SE, BioMonde Ltd., Bioventus LLC, Brightwake Ltd., Coloplast AS, ConvaTec Group Plc, DeRoyal Industries Inc., EZ Debride, Integra Lifesciences Corp., Labomar S.p.A, Lohmann and Rauscher GmbH and Co. KG, Medaxis AG, Mediwound Ltd., Medline Industries LP, Molnlycke Health Care AB, Pulsecare Medical LLC, RLS Global AB, Smith and Nephew plc, and Zimmer Biomet Holdings Inc.

Company Offering

Smith and Nephew Plc - The company offers wound debridement such as OASIS Matrix.

To gain access to more company profiles available with Technavio, buy the report!

The market is segmented by end-user (hospitals, clinics, and others), product (autolytic, surgical, mechanical, enzymatic, and others), and geography (North America, Europe, Asia, and Rest of the World (ROW)).

• The market share growth by the hospitals segment will be significant during the forecast period. It is due to the increasing incidence of acute and chronic wounds, increased surgical practice, improved awareness regarding technologically used debridement agents as well as a growing number of wound cases being treated in hospitals.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

"Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021"- Technavio

Wound Debridement Market: Market Dynamics

Key Drivers

• Technological advancements in wound debridement products
• Increasing prevalence of acute and chronic wounds
• Increasing volume of surgical procedures

Technological advancements in wound debridement products are a key factor driving market growth. Increased efforts in clinical and preclinical research have led to significant changes in the treatment of wounds. Patient care has also improved significantly, such as tracking wound healing, developing novel graft and coverage options, controlling inflammation, optimizing diet needs, and studying the effects of specific medicinal products. These combined efforts reduced the overall healthcare costs for patients and their healthcare providers, resulting in improved hospital survival rates as well as a decrease in average length of stay. For example, a new device made by ConvaTec Group plc, which was called InnovaBURN was given approval by the US Food and Drug Administration in March 2023. Similarly, an innovative technology to manage skin damage and protect vulnerable skin is the 3M Cavilon Advanced Skin Protector. Hence, the above-mentioned factors are expected to drive market growth during the forecast period. 

 Identify key trends, drivers, and challenges in the market. Download sample to gain access to this information.

Related Reports:

The soft tissue repair market is estimated to grow by USD 3,423.15 million at a CAGR of 4.5% between 2022 and 2027. This soft tissue repair market report extensively covers market segmentation by end-user (hospitals, ambulatory surgical services, and clinics), product (soft tissue fixation devices and accessories, cell therapy, and tissue scaffold), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). Reimbursement for soft tissue repair products is the key factor driving the growth of the market.

The microRNA (miRNA) market is estimated to grow by USD 2,020.12 million at a CAGR of 18.91% between 2022 and 2027. This microRNA (miRNA) market report extensively covers market segmentation by type (consumables and instruments), end-user (academic and government research institutes, biotechnology, and pharmaceutical companies, and CROs and clinical diagnostic centers), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The increasing prevalence of neurological disorders is the key driver for the growth of the market.

What are the key data covered in this wound debridement market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the wound debridement market between 2022 and 2027.
• Precise estimation of the wound debridement market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the wound debridement market across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of the wound debridement market companies.

ToC:

Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by End-User

Market Segmentation by Product

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis

Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio